{"height":"190","type":"rich","url":"https://okumi.hatenablog.com/entry/2021/08/29/203434","provider_name":"Hatena Blog","version":"1.0","provider_url":"https://hatena.blog","blog_url":"https://okumi.hatenablog.com/","categories":[],"html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fokumi.hatenablog.com%2Fentry%2F2021%2F08%2F29%2F203434\" title=\"Acceptability and feasibility of mifepristone-misoprostol for menstrual regulation in Bangladesh - \u30ea\u30d7\u30ed\u306a\u65e5\u8a18\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","author_name":"okumi","title":"Acceptability and feasibility of mifepristone-misoprostol for menstrual regulation in Bangladesh","blog_title":"\u30ea\u30d7\u30ed\u306a\u65e5\u8a18","image_url":null,"author_url":"https://blog.hatena.ne.jp/okumi/","width":"100%","published":"2021-08-29 20:34:34","description":"Menstrual regulations in Bangladesh pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov"}